Note purchase agreement and consulting agreement with G FarmaLabs Limited (Details Narrative) - USD ($)						1 Months Ended	12 Months Ended
	Jul. 11, 2023	Aug. 27, 2021	Aug. 27, 2021	Mar. 04, 2019	Mar. 17, 2017	Oct. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Aug. 31, 2022	Nov. 04, 2020	Apr. 24, 2019
G Farma Settlors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Litigation settlement amount awarded from other party	$ 2,539,597						$ 2,539,597
Litigation settlement default amount	2,494,450
Interest receivable	40,219						120,370
Litigation settlement costs	1,643
Attorneys fee	$ 3,285
Debt instrument, interest rate, effective percentage	10.00%
Other income							0	$ 3,550
Two promissory notes [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument, face amount											$ 1,166,570
G FarmaLabs Limited [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes receivable bad debt reserve							1,039,501	1,039,501
Notes receivable related party							0	0
Other income							$ 0	$ 3,550
G FarmaLabs Limited [Member] | Mentor partner I [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cost of impounded assets												$ 427,804
Notes purchase agreement [Member] | G FarmaLabs Limited [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument, face amount				$ 990,000	$ 500,000
Debt instrument, interest rate					7.42%
Debt instrument, maturity date					Apr. 15, 2022
Debt instrument, periodic payment				$ 10,239
Settlement agreement and mutual release [Member] | G Farma [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Liability for unpaid claims and claims adjustment expense schedule, discussion		The Settlement Agreement requires the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest are paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25% per annum, commencing February 25, 2021, compounded monthly, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%
Settlement agreement and mutual release [Member] | G Farma Settlors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Liability for unpaid claims and claims adjustment expense schedule, discussion			The Settlement Agreement requires the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest is paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25%, commencing February 25, 2021, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%
Liability for unpaid claims and claims adjustment expense, net		$ 500,000	$ 500,000			$ 500,000			$ 500,000	$ 500,000
Liability for unpaid claims and claims adjustment expense, adjustments		$ 2,000,000	$ 2,000,000			2,000,000			2,000,000	2,000,000
Remaining amount						494,450
Liability for accrued unpaid interest						$ 2,000,000			$ 2,000,000	$ 2,000,000